Cargando…

Early-onset colorectal cancer: A distinct entity with unique genetic features

The aim of the present study was to elucidate the genetic features of early-onset colorectal cancer (CRC), particularly the genetic mutations that may be regarded as prognostic and/or predictive markers in CRC and other malignancies. In total, 40 patients with non-polyposis CRC aged 35 or younger we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Dan, Shu, Chang, Lei, Chuanfen, Wan, Ying, Sun, Linyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406876/
https://www.ncbi.nlm.nih.gov/pubmed/32774506
http://dx.doi.org/10.3892/ol.2020.11894
_version_ 1783567503871442944
author Jiang, Dan
Shu, Chang
Lei, Chuanfen
Wan, Ying
Sun, Linyong
author_facet Jiang, Dan
Shu, Chang
Lei, Chuanfen
Wan, Ying
Sun, Linyong
author_sort Jiang, Dan
collection PubMed
description The aim of the present study was to elucidate the genetic features of early-onset colorectal cancer (CRC), particularly the genetic mutations that may be regarded as prognostic and/or predictive markers in CRC and other malignancies. In total, 40 patients with non-polyposis CRC aged 35 or younger were selected. The formalin-fixed, paraffin-embedded tumors acquired were subjected to mismatch repair (MMR) protein immunochemical staining and gene analysis with next-generation sequencing (44 exons, 17 genes; Ion Torrent Sequencing Platform). A total of 11 (27.5%) tumors presented with MMR protein deficiency (dMMR) and 26 (65%) tumors harbored one or more genetic mutations, including K-RAS proto-oncogene (35%), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA; 20%), B-Raf proto-oncogene (5%), erb-b2 receptor tyrosine kinase 2 (5%), discoidin domain receptor tyrosine kinase 2 (5%), N-RAS proto-oncogene (2.5%), KIT proto-oncogene (2.5%), TSC complex subunit 1 (2.5%), DNA methyltransferase 3 alpha (2.5%) and ABL proto-oncogene 1 (2.5%). Of the dMMR tumors, 81.8% (9/11) of cases presented with mutations in the tested genes, while only 58.6% (17/29) of the MMR-proficient (pMMR) tumors presented with these (P=0.158). PI3KCA was frequently mutated in dMMR tumors compared to pMMR tumors (P=0.025). In a subgroup with a family history of CRC, the dMMR status (P<0.001) and PIK3CA genetic mutation status (P=0.01) were more frequently observed compared to the other two groups (with a family history of other cancer types or no malignancy). Almost all patients who had relatives with CRC presented with both dMMR and other genetic mutations, while this was not observed in the patients who had relatives with other types of carcinoma. Certain genetic mutations that are rarely reported in CRC were only identified in those patients with a family history of carcinoma. In conclusion, non-polyposis CRC in young adults presents as a distinct entity with a unique set of genetic features. However, investigation of more cases in further studies is required to verify the present results.
format Online
Article
Text
id pubmed-7406876
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74068762020-08-06 Early-onset colorectal cancer: A distinct entity with unique genetic features Jiang, Dan Shu, Chang Lei, Chuanfen Wan, Ying Sun, Linyong Oncol Lett Articles The aim of the present study was to elucidate the genetic features of early-onset colorectal cancer (CRC), particularly the genetic mutations that may be regarded as prognostic and/or predictive markers in CRC and other malignancies. In total, 40 patients with non-polyposis CRC aged 35 or younger were selected. The formalin-fixed, paraffin-embedded tumors acquired were subjected to mismatch repair (MMR) protein immunochemical staining and gene analysis with next-generation sequencing (44 exons, 17 genes; Ion Torrent Sequencing Platform). A total of 11 (27.5%) tumors presented with MMR protein deficiency (dMMR) and 26 (65%) tumors harbored one or more genetic mutations, including K-RAS proto-oncogene (35%), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA; 20%), B-Raf proto-oncogene (5%), erb-b2 receptor tyrosine kinase 2 (5%), discoidin domain receptor tyrosine kinase 2 (5%), N-RAS proto-oncogene (2.5%), KIT proto-oncogene (2.5%), TSC complex subunit 1 (2.5%), DNA methyltransferase 3 alpha (2.5%) and ABL proto-oncogene 1 (2.5%). Of the dMMR tumors, 81.8% (9/11) of cases presented with mutations in the tested genes, while only 58.6% (17/29) of the MMR-proficient (pMMR) tumors presented with these (P=0.158). PI3KCA was frequently mutated in dMMR tumors compared to pMMR tumors (P=0.025). In a subgroup with a family history of CRC, the dMMR status (P<0.001) and PIK3CA genetic mutation status (P=0.01) were more frequently observed compared to the other two groups (with a family history of other cancer types or no malignancy). Almost all patients who had relatives with CRC presented with both dMMR and other genetic mutations, while this was not observed in the patients who had relatives with other types of carcinoma. Certain genetic mutations that are rarely reported in CRC were only identified in those patients with a family history of carcinoma. In conclusion, non-polyposis CRC in young adults presents as a distinct entity with a unique set of genetic features. However, investigation of more cases in further studies is required to verify the present results. D.A. Spandidos 2020-10 2020-07-17 /pmc/articles/PMC7406876/ /pubmed/32774506 http://dx.doi.org/10.3892/ol.2020.11894 Text en Copyright: © Jiang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Jiang, Dan
Shu, Chang
Lei, Chuanfen
Wan, Ying
Sun, Linyong
Early-onset colorectal cancer: A distinct entity with unique genetic features
title Early-onset colorectal cancer: A distinct entity with unique genetic features
title_full Early-onset colorectal cancer: A distinct entity with unique genetic features
title_fullStr Early-onset colorectal cancer: A distinct entity with unique genetic features
title_full_unstemmed Early-onset colorectal cancer: A distinct entity with unique genetic features
title_short Early-onset colorectal cancer: A distinct entity with unique genetic features
title_sort early-onset colorectal cancer: a distinct entity with unique genetic features
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406876/
https://www.ncbi.nlm.nih.gov/pubmed/32774506
http://dx.doi.org/10.3892/ol.2020.11894
work_keys_str_mv AT jiangdan earlyonsetcolorectalcanceradistinctentitywithuniquegeneticfeatures
AT shuchang earlyonsetcolorectalcanceradistinctentitywithuniquegeneticfeatures
AT leichuanfen earlyonsetcolorectalcanceradistinctentitywithuniquegeneticfeatures
AT wanying earlyonsetcolorectalcanceradistinctentitywithuniquegeneticfeatures
AT sunlinyong earlyonsetcolorectalcanceradistinctentitywithuniquegeneticfeatures